Researchers have developed a method for detecting malignant melanoma. A new type of patch equipped with microneedles can identify the biomarker tyrosinase directly in the skin.

The patch is equipped with micro-needles that can detect tyrosinase, an enzyme that is an important biomarker for malignant melanoma. By measuring the enzyme’s levels directly in the skin, researchers can quickly identify changes linked to the disease.

The researchers used human tissue from healthy individuals. By applying tyrosinase directly to the skin, they were able to mimic skin cancer.

Malignant melanoma is the most serious form of skin cancer and the fastest growing cancer. The study shows that the new patch could be an alternative to current diagnostic methods, leading to earlier detection and treatment of malignant melanoma. The researchers hope their work will help reduce the number of procedures and improve patients’ quality of life.

The method is less invasive than current methods and has the potential to provide faster and more reliable results compared to traditional biopsies. The researchers hope to improve the technique to offer more accurate and painless diagnostics. (Image Credit: Karolinska Institute)

For more information, visit here .

Topics:
Diseases Medical Medical equipment and supplies Medical, health and wellness Smart Patches and Bandages

More From SAE Media Group

Tech Briefs
Wearable Patch to Treat Melanoma
Related article image
Medical Design Briefs
Wearable Patch May Provide New Treatment Option for Skin Cancer
Related article image
Tech Briefs
Smart Bandages Monitor and Tailor Treatment for Chronic Wounds
Related article image
Medical Design Briefs
Cold Plasma Patch Could Make Immunotherapy More Effective for Treating Melanoma
Related article image
    Magazine cover
    Medical Design Briefs Magazine

    This article first appeared in the July, 2024 issue of Medical Design Briefs Magazine.

    Read more articles from this issue here.

    Read more articles from the archives here.